期刊文献+

不同病理类型脑转移瘤MRI表现特点 被引量:8

MRI features of different pathological types of brain metastases
下载PDF
导出
摘要 目的回顾性分析不同病理类型脑转移瘤磁共振(MR)平扫、弥散加权成像(DWI)特点及增强表现特点,探讨不同病理类型脑转移瘤MR表现特点,以期为临床提供影像学层面较为可靠的信息。方法分析兰州大学第一医院确诊不同病理类型187例脑转移瘤患者影像及临床资料,所有患者均行常规头颅MR平扫和增强检查,观察并记录脑转移瘤平扫信号、大小、数目、部位、病灶内出血及囊变坏死、病灶弥散特征、病灶强化方式及瘤周水肿程度。结果187例转移瘤颅内分布以幕上多见(占78.8%),腺癌直径多<1cm,鳞癌直径多>3cm;单发病灶63例,以肺鳞癌多见(23.8%,15/63),病灶较大且易发生囊变坏死并环形强化,瘤周水肿较重;多发病灶124例,以肺腺癌多见(43.5%,54/124)实质均匀强化且肺腺癌瘤内出血较常见;胰腺癌及乳腺癌脑膜转移多见(分别占54.5%,33.0%),脑膜呈团片状强化;弥散受限以肺小细胞癌脑转移瘤较为多见。结论不同病理类型脑转移瘤大小、数目、DWI信号特点、强化及瘤周水肿具有一定的特征性,对临床诊断具有一定的价值。 Objective To retrospectively analyze the MR plain,DWI and contrast-enhanced features of different pathological types of brain metastases,and to explore the MR features of those types of brain metastases,in order to provide more reliable information for clinical imaging.Methods The imaging and clinical data of 187 patients with brain metastasis diagnosed in The First Hospital of Lanzhou University were analyzed.All patients underwent routine cranial MR plain scan and contrast-enhanced examination.The signal,size,number,location,intracerebral hemorrhage and cystic necrosis,diffusion characteristics,enhancement mode and degree of peri-tumor edema of brain metastases were observed and recorded.Results The intracranial distribution of 187 cases of metastatic tumors was mostly supratentorial(78.8%),the diameter of adenocarcinoma was less than 1 cm,and the diameter of squamous cell carcinoma was more than 3 cm.63 cases were of single lesions,most of which were squamous cell carcinoma of the lung(23.8%,15/63).The lesions were large,prone to cystic necrosis and annular enhancement,and the peri-tumor edema was severe.In 124 cases of multiple lesions,lung adenocarcinoma was more common(43.5%,54/124)with homogeneous enhancement of parenchyma and intratumoral hemorrhage of lung adenocarcinoma.Meningeal metastasis of pancreatic cancer and breast cancer was more common(54.5%and 33.0%),showing meningeal mass enhancement,and DWI diffusion limitation was more common in brain metastases of small cell lung cancer.Conclusion The size,number,DWI signal characteristics,enhancement and peri-tumor edema of different pathological types of brain metastases have certain characteristics and certain value in clinical diagnosis.
作者 高玉岭 王帅文 张艳利 叶荣 冯雯 田水水 彭建鸿 郭顺林 雷军强 Gao Yu-ling;Wang Shuai-wen;Zhang Yan-li;Ye Rong;Feng Wen;Tian Shui-shui;Peng Jian-hong;Guo Shun-lin;Lei Jun-qiang(Department of Radiology,The First Hospital of Lanzhou University,Lanzhou 730000,China;Gansu Intelligent Imaging Medical Engineering Researching Center,Lanzhou 730000,China;Medical Imaging Center,Xi'an International Medical Center Hospital,Xi'an 710000,China)
出处 《兰州大学学报(医学版)》 CAS 2021年第2期65-70,共6页 Journal of Lanzhou University(Medical Sciences)
基金 兰州市人才创新创业项目(2017-RC-76)。
关键词 病理类型 转移瘤 磁共振表现 pathological type metastatic tumor magnetic resonance manifestation brain
  • 相关文献

参考文献13

二级参考文献117

  • 1窦平.出血性脑转移瘤的CT诊断[J].中国CT和MRI杂志,2006,4(4):8-10. 被引量:6
  • 2李威,陈敏,赵伟峰.肺癌脑转移瘤瘤内出血的影像学特点[J].中国医学影像技术,2004,20(8):1190-1192. 被引量:3
  • 3吴育连,范敏明,顾才校,彭淑牖,MichaelDuchrow德国吕贝克医科大学外科实验室,MonikaEingler,RainerBroll,Hans-Peter Bruch.胰腺癌的Ki-67抗原表达[J].中华实验外科杂志,1996,13(5):265-266. 被引量:4
  • 4谢锡驹,王水,郑伟,查小明.乳腺癌患者血清IGF-Ⅱ水平及其在肿瘤组织中的表达[J].江苏医药,2007,33(7):672-674. 被引量:5
  • 5Andersen TI, Paus E, NeslandJM, et al. Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB 2gene anaplification and C-erbB2 protein overexpression in tumour[J]. Acta Oncol, 1995, 34(4): 499-504.
  • 6Schippinger W, Dandachi N, Regitnig P, et al. The predictive value of EGFR and HER-2/neu in rumor tissue and serum for response to anthracycline--based neoadjuvant chemotherapy of breast cancer [J].J Clin Pathol, 2007, 128(4): 630-637.
  • 7Ali SM, Carney WP, Esteva FJ, et al. Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer[J]. Cancer, 2008, 113(6): 1294-1301.
  • 8Colomer R, Llombart-Cussac A, Lloveras B, et al. High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: a confirmatory prospective study[J]. Cancer, 2007, 110(10): 2178-2185.
  • 9Chakrabarty S, Huang S, Moskal TL, et al. Elevated serum levels of transforming growth factor--alpha in breast cancer patients[J]. Cancer Lett, 1994, 79(2): 157-160.
  • 10Papadopoulou E, Anagnostopoulos K, Tripsianis G, et al. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER--2 codon 655 polymorphism[J]. Neoplasma, 2008, 55(3): 229-238.

共引文献465

同被引文献68

引证文献8

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部